2022 ASTRO Annual Refresher Course onDemand

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of cancer patients. The course will review key evidence that forms the basis for current clinical practice guidelines and trends in new approaches. In addition, the course will cover implementation of hypofractionation in key disease sites as well as treatment of oligometastases and use of SBRT to improve outcomes for patients with metastatic disease.

Target Audience

The activity is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.

Learning Objectives

Upon completion of this activity, attendees should be able to do the following:

  • Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
  • Safely utilize the latest radiation technologies to improve patient care.
  • Incorporate hypofractionation into appropriate disease sites.
  • Appropriately incorporate the treatment of oligometastases into clinical practice.

 

Course summary
Available credit: 
  • 18.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 18.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 18.00 Certificate of Attendance
    This activity was designated for 18.00 AMA PRA Category 1 Credit™.
Course opens: 
03/28/2022
Course expires: 
03/27/2025
Cost:
$500.00
Rating: 
5

Name

Employment

Compensation/

Renumeration/Funding

Ownership/

Investment Interests

Leadership Positions

Meena Bedi, MD

Medical College of Wisconsin

Varian: Speaker's Bureau

None

Medical College of Wisconsin: Sarcoma Director: Director of sarcoma team

Julie Bradley, MD

University of Florida Proton Therapy Institute

Ion Beam Application: Travel Expenses: Relationship ended; Research grants: Research Grants

None

Medical Dosimetry Certification Board: Board Member: Relationship ended

Russell Hales, MD

Johns Hopkins University

None

None

None

Lara Hathout, MD, FRCPC

Rutgers Cancer Institute, New Brunswick, New Jersey Cervical Cancer

None

None

None

Emma Holliday, MD

MD Anderson Cancer Center

ASCO: Honoraria: Relationship ended 01/22/2022;
Merck: Research Grants

None

None

Theodore Hong, MD

Massachusetts General Hospital

Astra-Zenca: Research Grants
Bristol-Myers Squibb: Research Grants
IntraOp: Research Grants
Merck: Advisory Board
Synthetic Biologics: Consultant
Taiho: Research Grants
Tesaro: Research Grants

None

None

Bradford Hoppe, MD, MPH

Mayo Clinic, Jacksonville, Florida

None

None

PTCOG-NA: Secretary

Mitchel Kamrava, MD

Cedars-Sinai Cancer Institute, Los Angeles

None

None

ADROP: Board of Directors Member at Large
American Board of Radiology: Gyn Examiner
American Brachytherapy Society Board of Directors: Board of Directors Member at Large Brachytherapy Journal: Editor - Gyn section
Journal of Contemporary Brachytherapy: Co-Editor: Co-Editor

David Palma, MD, PhD

London Health Sciences Centre/Ontario Institute for Cancer Research

None

None

None

Murat Surucu, PhD

Stanford University

Reflexion Medical: Honoraria: Research Grants

None

None

Rahul Tendulkar, MD

Cleveland Clinic Tassug Cancer Institute

Varian Medical Systems: Honoraria

None

None

Mylin Torres, MD

Winship Cancer Institute, Emory University School of Medicine

BioAscend: Honoraria;
CDC: Honoraria
Genentech: Research Grants
MJHLife Sciences: Honoraria
NCI: Research Grants;
OncoHealth: Consultant
Pfizer: Consultant: Research Grants
Varian: Honoraria

None

Winship Cancer Institute of Emory University: Co-Leader, Cancer Prevention & Control Research Program: Research Lead

Phuoc Tran, MD

University of Maryland

AstraZeneca: Advisory Board: Relationship ended 09/11/2020
J&J: Consultant
Myovant : Advisory Board: Relationship ended 07/10/2020
RefleXion Medical Inc: Consultant

Natsar Pharm: Royalty/

Patent

None

Christina Tsien, MD

Johns Hopkins University

Blue Earth: Honoraria: Relationship ended
Merck: Honoraria: Speaker's Bureau: Travel Expenses: Relationship ended
Novocure: Advisory Board: Relationship ended
Tocagen: Honoraria: Relationship ended
Varian: Speaker's Bureau: Relationship ended 12/15/21

None

None

Sue Yom, MD

UCSF Bakar Precision Medicine Cancer Center/University of California, San Francisco

ASTRO: Honoraria
Bristol-Myers Squibb: Research Grants
Elsevier: Honoraria;
EMD Serono: Research Grants
National Institutes of Health: Research Grants
NRG Oncology: Research Grants
Springer: book chapter royalty
UpToDate: book chapter royalty

None

American Society for Radiation Oncology: Deputy Editor;
NRG Oncology: Chair

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 18.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 18.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 18.00 Certificate of Attendance
    This activity was designated for 18.00 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included
$0.00Included

Price

Cost:
$500.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

    Nonmember: $500
    Member: $375
    Member-in-Training: $200

Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason,  have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.”

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.